Clinical Trials
7 trialsNCT00433511 2026-05-29
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT04517838 2025-12-24
Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer
Mayo Clinic
Recruiting
NCT05447910 2025-06-15
Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer
Mayo Clinic
Terminated
NCT06977412 2025-05-18
The Application Value of Spectral CT in the Accurate Staging of Breast Cancer
Yunnan Cancer Hospital
Phase NA Not yet recruiting
NCT06671262 2025-02-11
NEOTRIO-HR
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT06805084 2025-02-03
H/ACA-ER
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Active not recruiting
NCT02282345 2022-07-06
Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Completed